Business Context and Reporting Period
Company: Bristol-Myers Squibb Company
Filing Type: Form 8-K (Current Report)
Date of Report: April 28, 2011
Event: Announcement of financial results for the first quarter of 2011.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. This 8-K serves as a notification that results were announced and incorporates the press release (Exhibit 99.1) and supplemental website information (Exhibit 99.2) by reference.
Material Changes
The filing text does not detail specific material changes versus the prior comparable period. Investors must refer to the incorporated press release for comparative data.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or unusual items. These details are contained within the referenced exhibits.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q1 2011 revenue and earnings figures.
- Access Exhibit 99.2 (Supplemental Information) on the company website for detailed financial breakdowns.
- Verify year-over-year growth rates and margin trends in the full press release.
- Check for any updated full-year guidance provided in the announcement.